Quick Answer
MYRIAD GENETICS INC reported Shares Outstanding of 93.50 million shares for fiscal year 2025.
MYRIAD GENETICS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 93.50M | +2.4% |
| 2024 | 91.30M | +1.6% |
| 2023 | 89.90M | +10.7% |
| 2022 | 81.20M | +1.5% |
| 2021 | 80.00M | +6.1% |
| 2020 | 75.40M | +0.9% |
| 2020 | 74.70M | +1.6% |
| 2019 | 73.50M | +4.1% |
| 2018 | 70.60M | +3.2% |
| 2017 | 68.40M | -1.0% |
| 2016 | 69.10M | +0.3% |
| 2015 | 68.90M | -6.3% |
| 2014 | 73.50M | -8.8% |
| 2013 | 80.60M | -2.4% |
| 2012 | 82.60M | -4.2% |
| 2011 | 86.24M | -8.3% |
| 2010 | 94.05M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 93.10M | +2.3% | +0.0% |
| June 30, 2025 | 93.10M | +2.4% | +1.0% |
| March 31, 2025 | 92.20M | +1.9% | +1.0% |
| December 31, 2024 | 91.30M | +1.6% | +0.3% |
| September 30, 2024 | 91.00M | +10.8% | +0.1% |
| June 30, 2024 | 90.90M | +11.0% | +0.4% |
| March 31, 2024 | 90.50M | +11.0% | +0.7% |
| December 31, 2023 | 89.90M | +10.7% | +9.5% |
- MYRIAD GENETICS INC showed an increase of +2.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, MYRIAD GENETICS INC’s shares outstanding has declined by 0.6% (from 94.05 million shares to 93.50 million shares).
- The most recent figure is from MYRIAD GENETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: